Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
63.70    -2.50 (-3.78%)
Bid:
63.40
Ask:
63.70
Spread: 0.30 (0.473%)
Market Cap: £562.74m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Share buyback programme

8 Oct 2021 07:00

RNS Number : 4317O
IP Group PLC
08 October 2021
 

FOR RELEASE ON

08 October 2021

 

 

IP Group plc - Share buyback programme

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that it has today launched a programme to purchase ordinary shares of 2 pence each in IP Group ("Ordinary Shares") up to an aggregate consideration of £35 million (the "Buyback Programme").

 

As previously announced and consistent with its Capital Allocation Policy, the Group's Board has specifically reserved up to £35 million for share buybacks. In light of the Group's prevailing share price, notwithstanding recent portfolio events, and consistent with its commitment to shareholder returns, the Board has determined that now is the appropriate time to formally launch the Buyback Programme.

 

The Group has entered into a non-discretionary arrangement with Numis to manage the Buyback Programme and repurchase Ordinary Shares on its behalf and within certain parameters, including to only buy back Ordinary Shares at a discount to Hard NAV per share. The Buyback Programme will run from the date of this announcement to 31 March 2022, unless terminated earlier. Numis will make its trading decisions in relation to the Ordinary Shares independently of the Group. 

Purchases of Ordinary Shares pursuant to the Buyback Programme will take place in open market transactions and may be made from time-to-time depending on market conditions, the Group's share price, trading volumes in the Group's Ordinary Shares and other factors. The maximum price paid per Ordinary Share will be: (A) no more than the higher of: (i) 5 per cent above the average of the middle market quotations taken from the London Stock Exchange Daily Official List for the five business days preceding any ordinary shares being purchased; and (ii) the price of the last independent trade and the highest independent bid for Ordinary Shares on the trading venue where the purchase is carried out; and (B) no less than (exclusive of expenses) a price of 2 pence per Ordinary Share, being the nominal value of an Ordinary Share. Under the Buyback Programme, any Ordinary Shares purchased will be held in treasury.

The Buyback Programme is in accordance with IP Group's general authority to purchase a maximum of 106,253,373 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 9 June 2021. The Buyback Programme will also be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019), and in accordance with Chapter 12 of the Financial Conduct Authority's Listing Rules. IP Group confirms that it currently has no other unpublished price sensitive information.

IP Group will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares by the Group as they occur.

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFDLLBFBLXFBD
Date   Source Headline
2nd Sep 201911:48 amRNSHolding(s) in Company
19th Aug 20192:25 pmRNSHolding(s) in Company
13th Aug 20193:31 pmRNSHolding(s) in Company
1st Aug 20194:19 pmRNSHolding(s) in Company
15th Jul 20197:09 amRNSCeres Power signs collaboration with Doosan
15th Jul 20197:00 amRNSIstesso announces positive P2a study of MBS2320
9th Jul 20191:35 pmRNSHolding(s) in Company
9th Jul 201910:50 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSAppointment of Non-executive Director
7th Jun 20195:12 pmRNSHolding(s) in Company
7th Jun 20191:19 pmRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
28th May 20196:04 pmRNSHolding(s) in Company
28th May 20195:42 pmRNSResult of AGM
28th May 201911:13 amRNSAppointment of Caroline Brown as NED
16th May 20196:21 pmRNSWithdrawal of resolution from 2019 AGM
3rd May 20199:38 amRNSAppointment of corporate broker
26th Apr 20196:23 pmRNSLTIP & DBSP awards; DBSP option exercise
18th Apr 20192:54 pmRNSAnnual Financial Report
15th Apr 201911:55 amRNSHolding(s) in Company
11th Apr 20197:12 amRNSDiurnal positive advice from EMA for Chronocort
26th Mar 20197:00 amRNSFinal Results
19th Mar 20193:32 pmRNSHolding(s) in Company
8th Mar 20192:20 pmRNSHolding(s) in Company
5th Mar 20195:54 pmRNSHolding(s) in Company
12th Feb 20199:36 amRNSDirector Declaration
12th Feb 20199:03 amRNSFLF aims for fusion by mid 2019 on Machine 3
28th Jan 20197:00 amRNSPortfolio co Featurespace completes £25m round
18th Jan 20191:25 pmRNSHolding(s) in Company
3rd Jan 20198:56 amRNSHolding(s) in Company
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration
18th Oct 20182:00 pmRNSAmgen invests £50m in Oxford Nanopore Technologies
15th Oct 20187:00 amRNSPortfolio co Garrison completes £22.9m financing
8th Oct 20187:07 amRNSPortfolio co Diurnal headline data for Chronocort
19th Sep 20189:51 amRNSDirector/PDMR Shareholding
17th Sep 20184:58 pmRNSDirector/PDMR Shareholding
17th Sep 20184:38 pmRNSDirector/PDMR Shareholding
17th Sep 201812:12 pmRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSAppointment of Chairman; Board changes
31st Aug 20189:55 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSGenomics announces Vertex leads £25m financing
29th Aug 20186:29 pmRNSIP Group plc -SAYE scheme
21st Aug 20187:06 amRNSCeres signs agreement with Bosch; £9m investment
10th Aug 20187:11 amRNSArtios Pharma completes £65m financing
31st Jul 20188:40 amRNSTR-1: NOTIFICATION
25th Jul 20187:00 amRNSHalf-yearly results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.